IBRITUMOMAB TIUXETAN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 34 adverse event reports in the FDA FAERS database where IBRITUMOMAB TIUXETAN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for IBRITUMOMAB TIUXETAN

Side Effect	Reports	%	Deaths	Hosp.
Sepsis	123	20.3%	119	24
Meningitis tuberculous	111	18.4%	111	20
Off label use	83	13.7%	41	29
Thrombocytopenia	75	12.4%	21	30
Myelodysplastic syndrome	72	11.9%	26	22
Progressive multifocal leukoencephalopathy	62	10.3%	47	24
Mucosal inflammation	56	9.3%	32	33
Neutropenia	55	9.1%	20	20
Anaemia	53	8.8%	12	28
Febrile neutropenia	49	8.1%	10	32
Acute myeloid leukaemia	44	7.3%	33	3
Pneumonia	32	5.3%	19	9
Respiratory failure	31	5.1%	31	16
Herpes simplex	28	4.6%	28	15
Platelet count decreased	28	4.6%	12	16